Advertisement

Onychomycosis pp 181-190 | Cite as

The Podiatric Approach

  • Tracey C. VlahovicEmail author
Chapter

Abstract

Podiatric physicians have a unique practice situation, as they generally manage onychomycosis cases on a daily basis and in a specialized population (diabetes, Chap.  17). However, toenail disease may be caused by a variety of issues that are specifically foot related and not fungal related: trauma from shoes, biomechanical issues and forces, and infection compounded by shoe gear and adjacent skin conditions to the nails (i.e., interdigital tinea pedis). It is important when discussing the management and treatment of toenail onychomycosis that the visually similar biomechanical causes of nail dystrophy are also mentioned.

Keywords

Lichen Planus Hallux Valgus Nail Plate Tinea Pedis Dermatophyte Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hay RJ, Baran R. Onychomycosis: A proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65:1219–27.CrossRefPubMedGoogle Scholar
  2. 2.
    Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 2003;149(Suppl):1–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Murphy F, Jiaravuthisan MM, Sasseville D, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1–27.CrossRefPubMedGoogle Scholar
  4. 4.
    Rich P, Elewski B, Scher RK, et al. Diagnosis, clinical implications, and complications of onychomycosis. Semin Cutan Med Surg. 2013;32(2Suppl 1):S5–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Moll JM. Seronegative arthropathies in the foot. Baillieres Clin Rheumatol. 1987;1(2):289–314.CrossRefPubMedGoogle Scholar
  6. 6.
    Fletcher CL, Hay RJ, Smeeton NC. Onychomycosis: the development of a clinical diagnostic aid for toenail disease. Part I. Establishing discriminating historical and clinical features. Br J Dermatol. 2004;150:701–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49(2):193–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Reisberger E-M, Abels C, Landthaler M, et al. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol. 2003;148(4):749–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Borkowski P, Williams M, Holewinski J, et al. Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques. J Am Podiatr Med Assoc. 2001;91(7):351–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Elewski BE. Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol. 1996;35:56–60.CrossRefGoogle Scholar
  11. 11.
    Arca E, Saracli MA, Akar A, et al. Polymerase chain reaction in the diagnosis of onychomycosis. Eur J Dermatol. 2004;14:52–5.PubMedGoogle Scholar
  12. 12.
    Pierard GE, Arrese-Estrada J, Pierard-Franchimont C. Treatment of onychomycosis: traditional approaches. J Am Acad Dermatol. 1993;29:S41–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Spreadbury C, Holden D, Aufaurre-Brown A, et al. Detection of aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol. 1993;31:615–21.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Miyakawa Y, Mabuchi T, Kagaya K, et al. Isolation and characterization of a species-specific DNA fragment for detection of Candida albicans by polymerase chain reaction. J Clin Microbiol. 1992;30:894–900.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Baharaeen S, Vishniac HS. 25S ribosomal RNA homologies of basidiomycetous yeasts: taxonomic and phylogenetic implications. Can J Microbiol. 1984;30:613–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Walberg M, Mørk C, Sandven P, et al. 18S rDNA polymerase chain reaction and sequencing in onychomycosis diagnostics. Acta Derm Venereol. 2006;86:223–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Potter LP, Mathias SD, Raut M, et al. The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis. J Dermatolog Treat. 2007;18:46–52.CrossRefPubMedGoogle Scholar
  18. 18.
    Malay DS, Yi S, Borowsky P, et al. Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. J Foot Ankle Surg. 2009;48:294–308.CrossRefPubMedGoogle Scholar
  19. 19.
    Jennings MB, Pollak R, Harkless LB, et al. Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial. J Am Podiatr Med Assoc. 2006;96:465–73.CrossRefPubMedGoogle Scholar
  20. 20.
    Vlahovic TC, Joseph WS, Scher RK, Tosti A, Plasencia J, Pariser DM, Markinson BC. Diagnosis and management of onychomycosis: perspectives from a joint podiatry-dermatology roundtable. J Am Podiatr Med Assoc. 2016;106(2):155–62.CrossRefPubMedGoogle Scholar
  21. 21.
    Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013;31(5):544–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Grover C, Bansal S, Nanda S, et al. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. Br J Dermatol. 2007;157(2):364–8.CrossRefGoogle Scholar
  23. 23.
    Pandhi D, Verma P. Nail avulsion: Indications and methods (surgical nail avulsion). Indian J Dermatol Venereol Leprol. 2012;78:299–308.CrossRefPubMedGoogle Scholar
  24. 24.
    Daniel CR 3rd, Tosti A, Iorizzo M, Piraccini BM. The disappearing nail bed: a possible outcome of onycholysis. Cutis. 2005;76(5):325–7.Google Scholar
  25. 25.
    Allevato MAJ. Diseases mimicking onychomycosis. Clin Dermatol. 2010;28:164–77.CrossRefPubMedGoogle Scholar
  26. 26.
    Bodman MA. Nail Dystrophies. Clin Podiatr Med Surg. 2004;21(4):663–87. viiiCrossRefPubMedGoogle Scholar
  27. 27.
    Zaiac MN, Daniel CR. Nails in systemic disease. Dermatol Ther. 2002;15(2):99–106.CrossRefGoogle Scholar
  28. 28.
    Zaias N, Rebell G, Casal G, Appel J. The asymmetric gait toenail unit sign. Skinmed. 2012;10(4):213–7.Google Scholar
  29. 29.
    Zaias N, Rebell G, Escovar S. Asymmetric gait nail unit syndrome: the most common worldwide toenail abnormality and onychomycosis. Skinmed. 2014;12(4):217–23.PubMedGoogle Scholar
  30. 30.
    Vlahovic TC, Schleicher SM. “Nail disorders” in skin disease of the lower extremities: a photographic guide, HMP Communications, 2012.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Podiatric MedicineTemple University School of Podiatric MedicinePhiladelphiaUSA

Personalised recommendations